Spectrum Pharmaceuticals Inc
10% Owner

Spectrum Pharmaceuticals Inc insider trades: CASI Pharmaceuticals (CASI) stock purchases

10% Owner, CASI Pharmaceuticals Last trade Dec 22, 2017 6 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2012
2
Companies
last trade 2017

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Spectrum Pharmaceuticals Inc reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 22, 2017CASI↑ Buy$9K
Dec 22, 2017CASI↑ Buy$6K
Oct 28, 2016CASI↑ Buy$11K
Oct 28, 2016CASI↑ Buy$7K
Jul 20, 2016CASI↑ Buy$7K
Jul 20, 2016CASI↑ Buy$5K
Feb 22, 2016CASI↑ Buy$10K
Feb 22, 2016CASI↑ Buy$7K
Sep 5, 2012ALTH↑ Buy$238.2M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Spectrum Pharmaceuticals Inc's insider trades

Spectrum Pharmaceuticals Inc is a 10% owner of CASI Pharmaceuticals (CASI). Since Sep 5, 2012, it has reported 9 open-market purchases worth $238.2M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CASI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.